Theron Pharmaceuticals, Inc. — Form D
Theron Pharmaceuticals, Inc. of LOS ALTOS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-05-19. The offering totals $1.0M, of which $663K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-05-19
- Form: D
- Accession: 0001458056-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $663K
- Remaining: $337K
- Minimum investment: $1
- Investors: 5
- Date of first sale: 2011-05-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-160043
Issuer
- Name: Theron Pharmaceuticals, Inc.
- CIK: 0001458056
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2009
- Address: 1500 OAK AVENUE, LOS ALTOS, CA, 94024
- Phone: 650-969-9260
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Allan Sundaram Kramer, M.D. | Director | Sunnyvale, CA |
| James Sundaram Larrick | Director | Sunnyvale, CA |
| Cary Sundaram Queen, Ph.D. | Director | Sunnyvale, CA |
| Meenakshi Sundaram Venkatraman | Executive Officer | Sunnyvale, CA |
| Xiaoming R Zhang | Director | Sunnyvale, CA |
| Xiaoming R Zhang | Executive Officer | Sunnyvale, CA |
| Allan W Kramer, M.D. | Director | Sunnyvale, CA |
| Jurg R Pfister | Director | Sunnyvale, CA |
| Jurg R Pfister | Executive Officer | Sunnyvale, CA |
| Cary W Queen, Ph.D. | Director | Sunnyvale, CA |
| Xiaoming Zhang | Director | Los Altos, CA |
| Xiaoming Zhang | Executive Officer | Los Altos, CA |
| James W Larrick | Director | Hayward, CA |
Other filings by this issuer (3)
More